Dr Punekar on the Evaluation of NT-112 in KRAS G12D+ Advanced Solid Tumors BySalman R. Punekar, MDJuly 2nd 2024Salman R. Punekar, MD discusses the rationale for evaluating safety and preliminary anti-tumor activity of NT-112 in solid tumors with the KRAS G12D mutation.
Dr Punekar on the Importance of Complete Biomarker Testing in Lung CancerBySalman R. Punekar, MDFebruary 22nd 2024Salman R. Punekar, MD, discusses the importance of complete biomarker testing and the landscape of biomarkers in lung cancer.